Managers / Q2 2019 · view latest →
Vident Investment Advisory, LLC
CIK 0001634047 · 1125 SANCTUARY PARKWAY, SUITE 515, ALPHARETTA, GA, 30009 · 404-487-1961
Summary
Vident Investment Advisory, LLC reported $1.2B in U.S.-listed holdings across 685 positions for Q2 2019.
Its largest position, SPY, represents 3.5% of the portfolio.
Compared with Q1 2019, the fund opened 21 new positions and exited 281.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 70.1% · $871M
- Closed-End Fund · 15.1% · $188M
- Other · 7.8% · $97M
- ETP · 3.5% · $43M
- ADR · 2.1% · $26M
- REIT · 1.4% · $18M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| OMCLOMNICELL INC | NEW | +159.1K | 159.1K | +$14M | $14M |
| ZIOPHARM ONCOLOGY INC | NEW | +278.6K | 278.6K | +$2M | $2M |
| ZYMEWORKS INC | NEW | +71.0K | 71.0K | +$2M | $2M |
| PRECISION BIOSCIENCES INC | NEW | +117.0K | 117.0K | +$2M | $2M |
| CRSPCRISPR THERAPEUTICS AG | NEW | +32.8K | 32.8K | +$2M | $2M |
| AUTLAUTOLUS THERAPEUTICS PLC | NEW | +90.4K | 90.4K | +$1M | $1M |
| EEFTEURONET WORLDWIDE INC | NEW | +3.7K | 3.7K | +$617,000 | $617,000 |
| ACIWACI WORLDWIDE INC | NEW | +17.1K | 17.1K | +$587,000 | $587,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2023 | $0 | 1 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $2.9B | 2,724 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $3.1B | 3,310 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $2.7B | 3,206 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $3.1B | 1,180 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $3.3B | 1,263 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $3.8B | 1,257 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $3.8B | 1,202 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $3.3B | 1,148 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $3.3B | 1,086 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $3.0B | 987 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.5B | 893 | Feb 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $2.0B | 866 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.9B | 1,392 | Jul 28, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2020 | $1.6B | 1,542 | May 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.6B | 976 | Feb 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1.1B | 702 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.2B | 685 | Aug 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.9B | 1,039 | May 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $1.8B | 1,125 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 5 additional managers.
- O'Shares Investment Advisers, LLC
- EXCHANGE TRADED CONCEPTS, LLC
- Amplify Investments, LLC
- Nationwide Fund Advisors
- Advisors Asset Management, Inc.
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.